Paper326378
Evidence on screening for breast cancer from a randomized trial.
Shapiro S. Cancer, 1977. Cited by 486 papers, by iCite.
Cite this record
ConductScience Library. Evidence on screening for breast cancer from a randomized trial. Papers, record 326378. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/326378
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Adult | |
| Age Factors | |
| Clinical Trials as Topic | |
| Female | |
| Humans | |
| Mammography | |
| Mass Screening | |
| Middle Aged | |
| New York | |
| Risk |
Source PubMed
Cited by108
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 486 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40876822 | Extending the Age Range in Mammography Screening: A Benefit-Risk Assessment from a Radiation Protection Perspective. | Rofo | 2026 | https://conductscience.org/library/papers/40876822 | PubMed |
| 40468448 | Matrix stiffness-induced IKBKE and MAPK8 signaling drives a phenotypic switch from DCIS to invasive breast cancer. | Cell Commun Signal | 2025 | https://conductscience.org/library/papers/40468448 | PubMed |
| 38752988 | Disparities in Mammography Screening: Analyzing Barriers to Access Using Individual Patient Perspectives and the Health Belief Model. | Cancer Control | 2024 | https://conductscience.org/library/papers/38752988 | PubMed |
| 37878149 | Breast cancer outcomes based on method of detection in community-based breast cancer registry. | Breast Cancer Res Treat | 2024 | https://conductscience.org/library/papers/37878149 | PubMed |
| 36453850 | Key concepts for informed health choices. 2.1: comparisons of treatments should be fair. | J R Soc Med | 2023 | https://conductscience.org/library/papers/36453850 | PubMed |
| 36005183 | Misinformation and Facts about Breast Cancer Screening. | Curr Oncol | 2022 | https://conductscience.org/library/papers/36005183 | PubMed |
| 34421215 | Mammograms and Mortality: How Has the Evidence Evolved? | J Econ Perspect | 2021 | https://conductscience.org/library/papers/34421215 | PubMed |
| 34199804 | Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I). | J Pers Med | 2021 | https://conductscience.org/library/papers/34199804 | PubMed |
| 30179570 | Limitations in the Effect of Screening on Breast Cancer Mortality. | J Clin Oncol | 2018 | https://conductscience.org/library/papers/30179570 | PubMed |
| 29402176 | Estimating the frequency of indolent breast cancer in screening trials. | Stat Methods Med Res | 2019 | https://conductscience.org/library/papers/29402176 | PubMed |
| 28591356 | Early detection of breast cancer in Brazil: data from the National Health Survey, 2013. | Rev Saude Publica | 2017 | https://conductscience.org/library/papers/28591356 | PubMed |
| 28493302 | Instrumental variables estimation of exposure effects on a time-to-event endpoint using structural cumulative survival models. | Biometrics | 2017 | https://conductscience.org/library/papers/28493302 | PubMed |
| 27100174 | Observed and Predicted Risk of Breast Cancer Death in Randomized Trials on Breast Cancer Screening. | PLoS One | 2016 | https://conductscience.org/library/papers/27100174 | PubMed |
| 25302030 | Impact of screening mammography on mortality from breast cancer before age 60 in women 40 to 49 years of age. | Curr Oncol | 2014 | https://conductscience.org/library/papers/25302030 | PubMed |
| 25114845 | Pathogenesis, prevention, diagnosis and treatment of breast cancer. | World J Clin Oncol | 2014 | https://conductscience.org/library/papers/25114845 | PubMed |
| 24536051 | Arguments against mammography screening continue to be based on faulty science. | Oncologist | 2014 | https://conductscience.org/library/papers/24536051 | PubMed |
| 24519768 | Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomised screening trial. | BMJ | 2014 | https://conductscience.org/library/papers/24519768 | PubMed |
| 24495817 | Measuring the mortality impact of breast cancer screening. | Can J Public Health | 2013 | https://conductscience.org/library/papers/24495817 | PubMed |
| 24218000 | The global challenge of reducing breast cancer mortality. | Oncologist | 2013 | https://conductscience.org/library/papers/24218000 | PubMed |
| 24212617 | Rational and irrational issues in breast cancer screening. | Cancers (Basel) | 2011 | https://conductscience.org/library/papers/24212617 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/326378
GET https://conductscience.org/api/papers/v1/326378/cited_by?page=2